75Pharma officially launches in the UK in Boots

Transforming pharmaceuticals with purpose: 75Pharma Ibuprofen 400mg soft capsules in UK Boots stores.

London, UK 8^th of October 2025 – 75Pharma, a purpose-driven impact company in the pharmaceutical industry, is proud to announce its official entry into the UK and product launch in leading health and beauty retailer Boots. Launching on the 13th of October 2025, 75Pharma’s first UK product, premium 75Pharma Ibuprofen 400mg soft capsules, will be introduced over 1000 Boots stores and online.

This milestone represents a major step forward in 75Pharma’s mission to redefine what it means to feel better, combining high-quality pharmaceutical products with an unwavering commitment to social good and environmental responsibility.

A new standard for purpose led pharmaceuticals

75Pharma is a pharmaceutical company that donates 75% of its distributable profits to good causes. With a business model rooted in transparency, sustainability, and trusted therapeutic efficacy, 75Pharma aims to disrupt the status quo of traditional pharmaceutical retail.

“We are proud to bring 75Pharma to the UK, one of Europe’s most dynamic and forward-thinking healthcare markets,” said Tessa Koivunen, CEO of 75Pharma. Our launch with Boots represents more than just a new product launch, it is a platform for us to introduce a new vision for healthcare. One where purpose meets pharmaceutical excellence. We believe consumers are ready for a brand that delivers both. We are excited to show what true impact means in practice, and to demonstrate that there is a better way to do business in pharma: one that prioritises people, the planet, and long-term value over short-term gain. We are proving that high impact and high-quality products are not mutually exclusive, and consumers deserve both.”

Debut product in Boots stores starting 13th of October: 75Pharma Ibuprofen 400mg soft capsules

75Pharma’s first UK product is a premium soft gel formulation of ibuprofen 400mg, offering fast and effective pain relief while maintaining the highest standards of quality and safety. The product will be available to Boots customers from 13^th of October 2025, with broader retailer and pharmacy distribution planned for late autumn.

Created for the conscious consumer, the new product reflects 75Pharma’s commitment to:

Environmentally responsible sourcing and manufacturing within Europe
Competitive pricing without ethical compromise
Effective high-quality products

Media & Partner Inquiries

75Pharma welcomes conversations with distributors, investors, healthcare providers, and media professionals.

Sales & Distribution: sales@75pharmagroup.com
Collaborations & Media: pr@75pharmagroup.com
Investor Relations: investorrelations@75pharmagroup.com
Website: www.75pharmagroup.com

About 75Pharma

75Pharma is an impact company built to create lasting change for people and the planet. With operations in London, Stockholm, and Helsinki, the company offers premium pharmaceutical products designed for conscious consumers who seek both therapeutic effectiveness and the opportunity to support ethical business practices. Its launch in the UK marks a significant step toward building a more responsible and sustainable pharmaceutical future, with further expansion as a first step into the Nordics planned as part of its broader European growth strategy.

75Pharma – A way to feel better